A randomized controlled trial of a vancomycin loading dose in children

Pediatric Infectious Disease Journal

Volumn 32, Issue 11, 2013, Pages 1217-1223

  Demirjian, Alicia ^a   Finkelstein, Yaron ^b,c,d,e   Nava Ocampo, Alejandro ^d   Arnold, Alana ^f   Jones, Sarah ^f   Monuteaux, Michael ^b   Sandora, Thomas J ^b   Patterson, Al ^f   Harper, Marvin B ^b  

^a Division of Infectious Diseases   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Department of Surgery   (United States)

^d Hospital for Sick Children   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f Department of Pharmacy ^*  (United States)

Author keywords

loading dose; methicillinresistant Staphylococcus aureus; pediatrics; pharmacokinetics; vancomycin

Indexed keywords

VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; OUTCOME ASSESSMENT; PHLEBITIS; PLASMA CONCENTRATION-TIME CURVE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RED MAN SYNDROME; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HOSPITALIZATION; HUMANS; MALE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84886952935     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182a26774     Document Type: Article

References (19)

1. Package Insert. Vancomycin Package Insert. Lake Forest, IL: Hospira, Inc. Revised September 2007.
2. M oise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43:925-942.
3. B rown J, Brown K, Forrest A. Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillinresistant Staphylococcus aureus and its association with attributable mortality during hospitalization. Antimicrob Agents Chemother. 2012;56:634-638.
4. R ybak MLB, Rotschafer JC, Moellering R Jr, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;1:82-98.
5. L iu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.
6. T ruong J, Levkovich BJ, Padiglione AA. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels. Intern Med J. 2012;42:23-29.
7. S chwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985;106:522-526.
8. Septic Shock: Initial Evaluation and Management in Children [Internet]. Waltham, MA: UpToDate, Inc; 2012.
9. Fleming S, Thompson M, Stevens R, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377:1011-1018.
10. Marsot A, Boulamery A, Bruguerolle B, et al. Vancomycin: a review of population pharmacokinetic analyses. Clin Pharmacokinet. 2012;51:1-13.
11. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
12. Murphy JE. Clinical Pharmacokinetics. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2008.
13. Wang JT, Fang CT, Chen YC, et al. Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother. 2001;47:246.
14. Mohammedi I, Descloux E, Argaud L, et al. Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg. Int J Antimicrob Agents. 2006;27:259-262.
15. Frymoyer A, Hersh AL, Benet LZ, et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009;28:398-402.
16. Gordon CL, Thompson C, Carapetis JR, et al. Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children. Pediatr Infect Dis J. 2012;31:1269-1271.
17. L e J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area-under-the-curve exposure. Pediatr Infect Dis J. 2013;32: e155-e163.
18. Finkelstein Y, Nava-Ocampo AA, Schechter T, et al. Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programs. Fundam Clin Pharmacol. 2009;23:53-57.
19. B roome L, So TY. An evaluation of initial vancomycin dosing in infants, children, and adolescents. Int J Pediatr. 2011;2011:470364.